Literature DB >> 27002257

Umbilical cord and preeclampsia.

M Olaya-C1, J Salcedo-Betancourt2, S H Galvis2, A M Ortiz2, S Gutierrez2, J E Bernal3.   

Abstract

INTRODUCTION: Preeclampsia is associated with abnormalities in the umbilical cord in several ways: morphological, biochemical and functional. Alteration in blood vessels of the placenta, decidua and circulatory system of the fetus might be related to factors that cause preeclampsia and may be associated with alterations of the umbilical cord.
OBJECTIVES: This study aimed to analyze the relationship between each type of umbilical cord abnormality and the different subtypes of hypertensive gestational disorders.
METHODS: We conducted a prospective study on consecutive autopsies and its placentas, looking for abnormalities in the umbilical cord's features and their clinical associations.
RESULTS: Umbilical cord abnormalities including length, diameter, insertion, entanglements, knots and coils were associated with maternal gestational hypertension.
CONCLUSION: In women with gestational hypertension, umbilical cord abnormalities are associated with fetal and neonatal consequences.

Entities:  

Keywords:  HELLP syndrome; Placenta; eclampsia; gestational hypertension; pregnancy

Mesh:

Year:  2016        PMID: 27002257     DOI: 10.3233/NPM-16814108

Source DB:  PubMed          Journal:  J Neonatal Perinatal Med        ISSN: 1878-4429


  2 in total

1.  The umbilical cord, preeclampsia and the VEGF family.

Authors:  Mercedes Olaya-C; Marta Garrido; Javier Hernandez-Losa; Marta Sesé; Paola Ayala-Ramirez; Rosa Somoza; Magda Jimena Vargas; Santiago Ramón Y Cajal
Journal:  Int J Womens Health       Date:  2018-11-28

2.  Biomarkers of Inflammation and Redox Imbalance in Umbilical Cord in Pregnancies with and without Preeclampsia and Consequent Perinatal Outcomes.

Authors:  Marilene Brandão Tenório Fragoso; Raphaela Costa Ferreira; Micaely Cristina Dos Santos Tenório; Fabiana Andréa Moura; Orlando Roberto Pimentel de Araújo; Nassib Bezerra Bueno; Marília Oliveira Fonseca Goulart; Alane Cabral Menezes de Oliveira
Journal:  Oxid Med Cell Longev       Date:  2021-11-09       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.